Tim Oldham work email
- Valid
- Valid
- Valid
- Valid
- Valid
Tim Oldham personal email
Tim Oldham phone numbers
An experienced life sciences executive, I grow and globalise innovation based businesses that solve global health and well-being challenges in senior executive and non-executive leadership roles. I currently focus on the biologics, cell therapy, gene therapy and Immunotherapy sectors.I bring more than a decade of direct life sciences business development, alliance management, market entry, and sales & marketing experience in Europe, Asia and Australia in pharmaceuticals, medical devices and biologics.My approach begins with customer/market needs, focussing teams on key sources of enterprise value, and developing strong teams, and relationships with boards and external partners. I bring a track record of fact-based, pragmatic problem solving in a range of business contexts and am not afraid to exit projects or businesses to achieve focus or improve performance.Results = great strategy + engaged, aligned teams + focused accountability
-
Ceo And Managing DirectorAdalta Ltd Oct 2019 - PresentMelbourne, Vic, AuAdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and then developed as a human protein. The result is a range of unique compounds, now known as i-bodies, for use in treating serious diseases. AdAlta is utilising the power of the i-body technology to create a pipeline of new drugs, with an initial focus on treating fibrotic diseases. -
Executive LeaderTijan Ventures Dec 2012 - PresentNew business creation, investment opportunity assessment, interim management and consulting. I lead firms in cell therapy, gene therapy and immunotherapy industries to design, implement and execute growth strategies and tactical operating plans with a particular focus on commercialising innovation and globalisation. I seek out and evaluate private investment opportunities and start up ventures.
-
Non-Executive DirectorAcrux Oct 2013 - PresentMelbourne, Vic, AuAcrux (ASX:ACR) is a dynamic Australian drug delivery business developing and commercialising a range of patient-preferred specialty and generic pharmaceutical products for global markets, using innovative, patented technology to administer drugs through the skin.Fast drying, non-occlusive topical sprays or liquids provide an enhanced transdermal delivery platform with low or no skin irritation, superior cosmetic acceptability, and simple, accurate and flexible dosing. -
Non Executive DirectorImunexus Ltd Sep 2018 - Jan 2020Imunexus is transforming therapeutic antibody performance by enabling rapid, low cost and relatively low risk creation of bispecific antibodies and proteins
-
Non-Executive DirectorRespiri Ltd Jan 2014 - Dec 2017Respiri (formerly iSonea) is a leader in the development of mobile health devices for the management of asthma, COPD and other chronic breathing conditions. iSonea’s proprietary apps, software and devices will help people monitor the symptoms of their conditions, increase their awareness of risk of attack, adhere to their medication plans, improve outcomes and reduce healthcare expenditures.
-
CeoCell Therapies Pty Ltd Apr 2014 - Aug 2017Melbourne, Vic, AuCell Therapies Pty Ltd is the leading manufacturer and distributor of cellular therapies in Asia Pacific.As late stage and approved cellular therapy product numbers grow, scaling manufacturing up and out to reliably deliver a time sensitive, patient specific product with needle-to-needle control is becoming THE challenge facing the cell based therapies industry. Cell Therapies’ unique expertise is solving this challenge and we are now building on this expertise to grow our contract manufacturing and approved product distribution business into SE Asia. These markets comprise more than 650 million people and are some of the fastest growing healthcare markets in the world.Cell Therapies has more than eleven years experience with a wide range of cellular therapies for clinical trial and approved therapeutic uses. We have developed multiple processes for leading stem cell companies, that have been successfully transferred to global manufacturing networks. Cell Therapies has maintained an enviable Therapeutic Goods Administration (TGA) record at our Melbourne facilities within the Peter MacCallum Cancer Centre; and licensed our quality system to support cGMP compliance at several other facilities across Asia. The company is actively building the capabilities and client portfolio to ensure access to cell based therapies for patients across the region. -
President, Asia PacificHospira Feb 2007 - Nov 2012Lake Forest, Il, UsDelivered safer and more productive intravenous drug therapy across Asia Pacific through a team of more than 400 commercial operations staff in ten countries. Achievements included establishing operations in South Korea and China; establishing (oncology) and maintaining (acute care) strategic alliances in Japan; developing innovative new product and service combinations based on customer needs in Australia (central nervous system drugs, devices and software) and China (low cost infusion management devices); and improving tendering and sales force effectiveness across the region. Total sales more than $300m, EBIT more than $75m, greater than 10% annual growth in Asia, greater than 25% in Japan and China -
Acting Head, Emea And Vp Strategic PartnershipsMayne Pharma Mar 2006 - Jan 2007Led hospital injectable drug commercial operations across Europe and Middle East including preparing for integration with Hospira, overseeing business development and strategic marketing, managing six strategic alliances in India (oncology manufacturing JV, antibiotic in-licensing), Germany (contract manufacturing) and Croatia (biosimilars) and leading sales teams in 11 countries. ~EUR250m sales, 300 staff
-
Vp Business Development, Planning & Operations EffectivenessMayne Pharma Feb 2003 - Jan 2007Responsible for business development, strategic marketing, integration and alliance management. Built a centre of integration excellence. Created a pan-EU marketing function. Managed a pipeline of 20 new molecules across 35 markets including three pan-EU first to market launches and four other launches. Completed 11 transactions accessing 10 generic injectables, two biosimilars and one proprietary oncology molecule as well as Spanish subsidiary. Integrated UK chemotherapy compounding acquisition. Chair of the EGA Biosimilars Working Group that influenced in the creation of the European biosimilars market at European Commission, European Medicines Agency, WHO
-
Global Projects ManagerMayne Pharma Jul 2002 - Feb 2003Developed commercialisation strategies for step out growth ventures including biosimilars, a gene therapy for prostate cancer and proprietary drug delivery platforms
-
Associate And Then Engagement ManagerMckinsey & Company Mar 1997 - Nov 2001UsKey project leadership role with pre-eminent global management consulting firm. Responsible for problem solving, client relationship and project team leadership on projects spanning a wide range of industries including healthcare, wheat, forestry, biotechnology and a range of executive management responsibilities including strategy, sales force effectiveness and direct and indirect operations productivity.
Tim Oldham Skills
Tim Oldham Education Details
-
Imperial College LondonPhysical Chemistry -
Australian Institute Of Company DirectorsGraduate - Company Directors Course
-
University Of Technology SydneyLaw
-
The Australian National UniversityChemistry And Intellectual Property
Frequently Asked Questions about Tim Oldham
What company does Tim Oldham work for?
Tim Oldham works for Adalta Ltd
What is Tim Oldham's role at the current company?
Tim Oldham's current role is CEO and Managing Director at AdAlta Ltd.
What is Tim Oldham's email address?
Tim Oldham's email address is ti****@****.com.au
What is Tim Oldham's direct phone number?
Tim Oldham's direct phone number is (224) 212*****
What schools did Tim Oldham attend?
Tim Oldham attended Imperial College London, Australian Institute Of Company Directors, University Of Technology Sydney, The Australian National University.
What skills is Tim Oldham known for?
Tim Oldham has skills like Pharmaceutical Industry, Strategy, Biotechnology, Oncology, Medical Devices, Business Development, Leadership, Life Sciences, Strategic Planning, Lifesciences, Management, Mergers And Acquisitions.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial